JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 6 No. 10 699-704
© 1965 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burke, G.
Right arrow Articles by Feldman, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burke, G.
Right arrow Articles by Feldman, J. M.

Radioactive Iodine Treatment of Intractable Angina Pectoris

Gerald Burke, M.D. and Jerome M. Feldman, M.D.1

Chicago, Illinois

ABSTRACT

The effectiveness of 131I ablative therapy in a series of 80 patients with intractable angina pectoris is evaluated. Meaningful follow-up information was available in 48 patients who constituted the actual study group. Thirty of 39 patients (76 per cent) rendered hypothyroid showed significant improvement. However, six of nine patients remaining euthyroid also showed significant improvement.

This study also affords a comparison of the single and multiple dose forms of 131I therapy and, aside from an apparent decrease in the incidence of radiation thyroiditis, no significant difference between these two forms of 131I therapy was noted. No attempt was made to compare the evolution of the anginal syndrome in a similar control group, and no allowance was made for the possible contributory role of other forms of medical therapy after the administration of radioactive iodine. No estimate of the effect of 131I therapy on survival was attempted.

Although the results achieved in this study are entirely comparable to those previously reported, the virtually identical improvement rate obtained in the smaller group of patients remaining euthyroid would seem to preclude meaningful assessment of the efficacy of this form of therapy.

FOOTNOTES

1 From the Radioisotope Laboratory, Department of Metabolism and Endocrinology, Division of Medicine, Michael Reese Hospital and Medical Center, Chicago, Illinois.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1965 by the Society of Nuclear Medicine.